- Published at
- by seekingalpha.com
positive
positive
Amarin Is A Sell Despite The Large Cash Balance (NASDAQ:AMRN)
Amarin faces revenue declines due to generic competition, with losses outpacing revenue. Explore challenges, risks, and M&A potential. Learn more on AMRN stock here.